gabapentin has been researched along with Depressive Disorder in 13 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Depressive Disorder: An affective disorder manifested by either a dysphoric mood or loss of interest or pleasure in usual activities. The mood disturbance is prominent and relatively persistent.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 8.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "To determine if gabapentin is effective either as adjunctive treatment or as monotherapy for major affective disorders in a naturalistic setting." | 7.70 | Gabapentin treatment of mood disorders: a preliminary study. ( Desai, SP; Ghaemi, SN; Goodwin, FK; Katzow, JJ, 1998) |
| "To provide a qualitative, systematic update and review of the pharmacology, pharmacokinetics, efficacy in mood disorders, adverse effects, and costs of lamotrigine." | 4.81 | Lamotrigine update and its use in mood disorders. ( Hurley, SC, 2002) |
| "A chart review was conducted on 27 outpatients presenting with a depressive disorder in whom gabapentin was added to ongoing treatment with a conventional antidepressant to which patients had not responded after at least 6 weeks." | 3.71 | Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review. ( Carpenter, LL; Leon, Z; Price, LH; Siniscalchi, JM; Yasmin, S, 2001) |
| "To determine if gabapentin is effective in monotherapy or add-on treatment of non-refractory bipolar disorder in open prospective treatment." | 3.71 | Gabapentin treatment of the non-refractory bipolar spectrum: an open case series. ( Ghaemi, SN; Goodwin, FK, 2001) |
| "To determine if gabapentin is effective either as adjunctive treatment or as monotherapy for major affective disorders in a naturalistic setting." | 3.70 | Gabapentin treatment of mood disorders: a preliminary study. ( Desai, SP; Ghaemi, SN; Goodwin, FK; Katzow, JJ, 1998) |
| "Forty adult patients with partial epilepsy were studied in a prospective, non-randomized fashion with interviewer-rated and self-rated scales of mood and anxiety: the Cornell Dysthymia Rating Scale (CDRS), Beck Depression Inventory (BDI), and Hamilton Depression (Ham-D) and Anxiety (Ham-A) Scales." | 2.69 | A beneficial effect on mood in partial epilepsy patients treated with gabapentin. ( Carson, D; Goldstein, MA; Harden, CL; Kocsis, JH; Labar, DR; Lazar, LM; Nikolov, B; Pick, LH; Ravdin, LD, 1999) |
| "Cases with EoE with a psychiatric diagnosis were more likely to be women, white, and 18 years or older and to have a longer symptom duration before diagnosis." | 1.56 | Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation. ( Corder, SR; Dellon, ES; Eluri, S; Kim, E; Reed, CC; Sanders, E; Tappata, M, 2020) |
| "All patients had substance use disorders, the large majority (72 %) to more than one substance." | 1.43 | Abuse of Gabapentin is Associated with Opioid Addiction. ( Bastiaens, L; Galus, J; Mazur, C, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (30.77) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 1 (7.69) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Reed, CC | 1 |
| Corder, SR | 1 |
| Kim, E | 1 |
| Sanders, E | 1 |
| Tappata, M | 1 |
| Eluri, S | 1 |
| Dellon, ES | 1 |
| van den Driest, JJ | 1 |
| Schiphof, D | 1 |
| de Wilde, M | 1 |
| Bindels, PJE | 1 |
| van der Lei, J | 1 |
| Bierma-Zeinstra, SMA | 1 |
| Bastiaens, L | 1 |
| Galus, J | 1 |
| Mazur, C | 1 |
| Yatham, LN | 1 |
| Howland, RH | 1 |
| Skolnick, AA | 1 |
| Manack, L | 1 |
| Ghaemi, SN | 2 |
| Katzow, JJ | 1 |
| Desai, SP | 1 |
| Goodwin, FK | 2 |
| Harden, CL | 1 |
| Lazar, LM | 1 |
| Pick, LH | 1 |
| Nikolov, B | 1 |
| Goldstein, MA | 1 |
| Carson, D | 1 |
| Ravdin, LD | 1 |
| Kocsis, JH | 1 |
| Labar, DR | 1 |
| Maurer, I | 1 |
| Volz, HP | 1 |
| Sauer, H | 1 |
| Yasmin, S | 1 |
| Carpenter, LL | 1 |
| Leon, Z | 1 |
| Siniscalchi, JM | 1 |
| Price, LH | 1 |
| Robillard, M | 1 |
| Conn, D | 1 |
| Hurley, SC | 1 |
3 reviews available for gabapentin and Depressive Disorder
| Article | Year |
|---|---|
Newer anticonvulsants in the treatment of bipolar disorder.
Topics: Acetates; Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Dep | 2004 |
Anticonvulsant drug therapies.
Topics: Amines; Anticonvulsants; Bipolar Disorder; Carbamazepine; Cyclohexanecarboxylic Acids; Depressive Di | 2005 |
Lamotrigine update and its use in mood disorders.
Topics: Acetates; Aggression; Amines; Antidepressive Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids; | 2002 |
1 trial available for gabapentin and Depressive Disorder
| Article | Year |
|---|---|
A beneficial effect on mood in partial epilepsy patients treated with gabapentin.
Topics: Acetates; Adult; Affect; Aged; Amines; Anticonvulsants; Anxiety Disorders; Comorbidity; Cyclohexanec | 1999 |
9 other studies available for gabapentin and Depressive Disorder
| Article | Year |
|---|---|
Psychiatric Comorbidities and Psychiatric Medication Use Are Highly Prevalent in Patients With Eosinophilic Esophagitis and Associate With Clinical Presentation.
Topics: Adolescent; Adult; Age Distribution; Anxiety Disorders; Benzodiazepines; Chest Pain; Child; Chronic | 2020 |
Antidepressant and anticonvulsant prescription rates in patients with osteoarthritis: a population-based cohort study.
Topics: Aged; Analgesics; Anticonvulsants; Antidepressive Agents; Depressive Disorder; Drug Prescriptions; F | 2021 |
Abuse of Gabapentin is Associated with Opioid Addiction.
Topics: Adult; Amines; Attention Deficit Disorder with Hyperactivity; Comorbidity; Criminals; Cyclohexanecar | 2016 |
Science reporters hear wide range of recent data at 12th annual conference.
Topics: Acetates; Aged; AIDS Vaccines; American Medical Association; Amines; Animals; Anticonvulsants; beta- | 1993 |
Gabapentin treatment of mood disorders: a preliminary study.
Topics: Acetates; Adolescent; Adult; Aged; Ambulatory Care; Amines; Anticonvulsants; Antidepressive Agents; | 1998 |
Gabapentin leads to remission of somatoform pain disorder with major depression.
Topics: Acetates; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Depressive Disorder; Female; Gabapen | 1999 |
Adjunctive gabapentin in treatment-resistant depression: a retrospective chart review.
Topics: Acetates; Adult; Amines; Anti-Anxiety Agents; Cyclohexanecarboxylic Acids; Depressive Disorder; Dose | 2001 |
Gabapentin treatment of the non-refractory bipolar spectrum: an open case series.
Topics: Acetates; Adult; Amines; Antimanic Agents; Bipolar Disorder; Cyclohexanecarboxylic Acids; Depressive | 2001 |
Gabapentin use in geriatric patients with depression and bipolar illness.
Topics: Acetates; Aged; Aged, 80 and over; Amines; Antidepressive Agents; Bipolar Disorder; Cyclohexanecarbo | 2001 |